Morgan Creek Capital Management, LLC reported 15 positions worth $148.41M for the quarter ended Jun 30, 2026, down 2.0% on the prior quarter. It opened 7 new positions, added to 2, trimmed 1 and exited 1. Its largest holding is Figure Technology Solutions, Inc. at 91.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| FIGR Figure Technology Solutions, Inc. | +566.1K | +14.6% | $17.38M | 91.93% |
| BHVN Biohaven Ltd. | +18.2K | – | $270.71K | 0.182% |
| ACAD Acadia Pharmaceuticals Inc | +9,395 | – | $237.69K | 0.16% |
| MANE Veradermics, Inc | +1,925 | – | $236.66K | 0.159% |
| AVBP ArriVent BioPharma, Inc. | +6,600 | – | $229.28K | 0.154% |
| PTCT Ptc Therapeutics, Inc. | +2,752 | – | $224.48K | 0.151% |
| TSM Taiwan Semiconductor Manufacturing Co Ltd | +453 | – | $216.34K | 0.146% |
| REGN Regeneron Pharmaceuticals, Inc. | +332 | – | $207.02K | 0.139% |
| INSM INSMED Inc | +678 | +54.2% | $72.29K | 0.139% |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| BHVN Biohaven Ltd. | +18.2K | $270.71K | 0.182% |
| ACAD Acadia Pharmaceuticals Inc | +9,395 | $237.69K | 0.16% |
| MANE Veradermics, Inc | +1,925 | $236.66K | 0.159% |
| AVBP ArriVent BioPharma, Inc. | +6,600 | $229.28K | 0.154% |
| PTCT Ptc Therapeutics, Inc. | +2,752 | $224.48K | 0.151% |
| TSM Taiwan Semiconductor Manufacturing Co Ltd | +453 | $216.34K | 0.146% |
| REGN Regeneron Pharmaceuticals, Inc. | +332 | $207.02K | 0.139% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| U Unity Software Inc. | -9,345 | $205.03K | 0.135% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | FIGR Figure Technology Solutions, Inc. | Financial Services | 4.44M | $136.42M | 91.93% | +566.1K | +14.6% | Added | 2.48% |
| 2 | UBER Uber Technologies, Inc | Technology | 45.0K | $3.25M | 2.19% | 0 | 0.0% | Unchanged | 0% |
| 3 | GEMI Gemini Space Station, Inc. | Financial Services | 562.2K | $2.40M | 1.61% | -2.09M | -78.8% | Reduced | 0.43% |
| 4 | LYFT Lyft, Inc. | Technology | 97.7K | $1.43M | 0.962% | 0 | 0.0% | Unchanged | 0.03% |
| 5 | YMM Full Truck Alliance Co. Ltd. | Technology | 174.1K | $1.41M | 0.953% | 0 | 0.0% | Unchanged | 0.02% |
| 6 | IHS IHS Holding Ltd | Real Estate | 155.0K | $1.28M | 0.86% | 0 | 0.0% | Unchanged | 0.05% |
| 7 | PAA Plains All American Pipeline Lp | Energy | 17.6K | $392.71K | 0.265% | 0 | 0.0% | Unchanged | 0% |
| 8 | BHVN Biohaven Ltd. | Healthcare | 18.2K | $270.71K | 0.182% | +18.2K | – | New | 0.01% |
| 9 | ACAD Acadia Pharmaceuticals Inc | Healthcare | 9,395 | $237.69K | 0.16% | +9,395 | – | New | 0.01% |
| 10 | MANE Veradermics, Inc | Healthcare | 1,925 | $236.66K | 0.159% | +1,925 | – | New | 0% |
| 11 | AVBP ArriVent BioPharma, Inc. | Healthcare | 6,600 | $229.28K | 0.154% | +6,600 | – | New | 0.01% |
| 12 | PTCT Ptc Therapeutics, Inc. | Healthcare | 2,752 | $224.48K | 0.151% | +2,752 | – | New | 0% |
| 13 | TSM Taiwan Semiconductor Manufacturing Co Ltd | Technology | 453 | $216.34K | 0.146% | +453 | – | New | 0% |
| 14 | REGN Regeneron Pharmaceuticals, Inc. | Healthcare | 332 | $207.02K | 0.139% | +332 | – | New | 0% |
| 15 | INSM INSMED Inc | Healthcare | 1,929 | $205.67K | 0.139% | +678 | +54.2% | Added | 0% |
Tip. Select a row to see that position’s full history at Morgan Creek Capital Management.
As of its Q2 2026 13F filing, Morgan Creek Capital Management, LLC’s five largest positions were Figure Technology Solutions, Inc. (FIGR) at 91.9%, Uber Technologies, Inc (UBER) at 2.2%, Gemini Space Station, Inc. (GEMI) at 1.6%, Lyft, Inc. (LYFT) at 1.0%, Full Truck Alliance Co. Ltd. (YMM) at 1.0% of the reported portfolio.
Morgan Creek Capital Management, LLC reported a 13F portfolio worth $148.41M across 15 positions for Q2 2026. That is down 2.0% from the previous quarter.
Its largest purchases by value were Figure Technology Solutions, Inc. ($17.38M), Biohaven Ltd. ($270.71K), Acadia Pharmaceuticals Inc ($237.69K). It opened 7 new positions.
Its largest sales by value were Gemini Space Station, Inc. ($8.89M), Unity Software Inc. ($205.03K). It exited 1 positions entirely.
From the Form 13F-HR reports Morgan Creek Capital Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.